SCHEMBL24876661

SCHEMBL24876661

O=c1[nH]c2cc(F)c(S(=O)(=O)Nc3ccc4c(c3)CCCC4)cc2[nH]c1=O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ THRB P10828 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PKM P14618 8/20 0.44
▸ POLB P06746 1/20 0.43
▸ DPP4 P27487 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24876646 0.85 LMNA (0.65) LMNAMEN1KMT2AALDH1A1THRB
SCHEMBL31679802 0.85 LMNA (0.55) LMNAMEN1KMT2AALDH1A1THRB
SCHEMBL24876656 0.83 LMNA (0.65) LMNAMEN1KMT2AALDH1A1THRB
SCHEMBL24876161 0.78 KMT2A (0.55) LMNAMEN1KMT2ATHRBSMN1; SMN2
SCHEMBL31679999 0.77 MEN1 (0.47) LMNAMEN1KMT2AALDH1A1THRB
SCHEMBL24876751 0.76 LMNA (0.48) LMNAMEN1KMT2AALDH1A1THRB
SCHEMBL24876746 0.76 ACLY (0.56) LMNAMEN1KMT2ATHRBPKM
SCHEMBL31679859 0.76 THRB (0.57) LMNAMEN1KMT2ATHRBPKM
SCHEMBL24876665 0.76 THRB (0.57) LMNAMEN1KMT2ATHRBPKM
SCHEMBL24876015 0.76 MEN1 (0.61) LMNAMEN1KMT2AALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367103-B1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-09-03 — — EP disclosed
WO-2023280970-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-01-12 — — WO disclosed
Send feedback